Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pilot study of skin allergy testing methods for salvianolate injection
ChiCTR-DNRC-13003367Phase 4Completed
- Sponsor
- The Second Hospital of Tianjin Medical University
- Start
- Sep 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of salvianolate in drug allergy (2 arms), sponsored by The Second Hospital of Tianjin Medical University. Primary endpoint: Skin allergy. Started Sep 2014; status: completed.
02
Drugs
salvianolate
03
Conditions
drug allergy
Beyond the preview
Go deeper on ChiCTR-DNRC-13003367.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-DNRC-13003367.